Senomyx Inc.  

(Public, NASDAQ:SNMX)   Watch this stock  
Find more results for Edward A. Snyder
+0.01 (0.32%)
Feb 11 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.99 - 3.23
52 week 2.84 - 7.80
Open 3.02
Vol / Avg. 132,617.00/212,208.00
Mkt cap 144.24M
P/E     -
Div/yield     -
EPS -0.29
Shares 44.45M
Beta 1.42
Inst. own 59%
Feb 24, 2016
Q4 2015 Senomyx Inc Earnings Release (Estimated) Add to calendar
Jan 13, 2016
Senomyx Inc at Needham Growth Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -32.53% -43.92%
Operating margin -32.65% -44.06%
EBITD margin - -35.96%
Return on average assets -28.35% -30.46%
Return on average equity -46.66% -56.20%
Employees 110 -
CDP Score - -


4767 Nexus Centre Drive
United States - Map
+1-858-6468300 (Phone)
+1-858-4040752 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Senomyx, Inc. is focused on using taste receptor technologies to discover, develop and commercialize flavor ingredients for the packaged food, beverage and ingredient supply industries to improve the nutritional profile of their products and generate cost of goods savings while maintaining or improving taste. The Company is engaged in the discovery, development and/or commercialization of flavor ingredients through five programs focused on sweet, savory, bitter, cooling and salt taste areas. It has developed taste receptor-based assays for use in its screening systems and to screen its compound libraries and identify potential flavor ingredients. It has identified S2383, a modifier of the sweetener sucralose; S6973 and S9632, two modifiers of sucrose, or common table sugar, and S617, a modifier of sucrose and high fructose corn syrup. It has also identified several sample classes of new cooling agents that demonstrate a taste proof-of-concept and display cooling properties.

Officers and directors

Kent Snyder Chairman of the Board
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John W. Poyhonen President, Chief Executive Officer, Director
Age: 55
Bio & Compensation  - Reuters
Antony E. Rogers Chief Financial Officer, Senior Vice President
Age: 48
Bio & Compensation  - Reuters
Sharon Wicker Senior Vice President, Chief Commercial Development Officer
Age: 59
Bio & Compensation  - Reuters
Jay M. Short Ph.D. Lead Independent Director
Age: 56
Bio & Compensation  - Reuters
Daniel Edward Stebbins Director
Bio & Compensation  - Reuters
Roger D. Billingsley Ph.D. Independent Director
Age: 63
Bio & Compensation  - Reuters
Stephen A. Block Esq. Independent Director
Age: 70
Bio & Compensation  - Reuters
Mary Ann Gray Ph.D. Independent Director
Age: 62
Bio & Compensation  - Reuters